◆ 会议时间：2024年4月27日至30日
◆ 会议地点：西班牙 巴塞罗那

◆ 会议简介：

2024年第34届欧洲临床微生物与传染病学大会(ECCMID2024)将于2024年4月27日至30日在西班牙巴塞罗那举行，会议由欧洲临床微生物学与感染病学会（ESCMID）主办。ECCMID是临床微生物学、感染性疾病和感染控制领域规模最大、内容最全面、最具影响力的国际会议，汇集了来自众多领域的国际专家，向14000多名来自世界各地的同行介绍他们的最新发现、指南和经验；大会将利用最新的技术呈现最科学的教育计划，包括主题演讲、座谈会、海报会议、教育研讨会、专家会面、展览会等多种形式。

欧洲临床微生物和感染病学会(ESCMID)成立于1983年，是一个致力于通过促进研究、教育、培训、医疗实践提高感染相关疾病的诊断、治疗和预防水平的非营利组织，是欧洲领先的临床微生物学和感染病学会宣。30多年来，ESCMID已经成微生物学家和感染病专家职业生涯最有影响力的组成部分，现在世界各地拥有7000多名个人会员和30,000余名附属成员（未经本站许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)

ESCMID于每年春季举办欧洲临床微生物与感染病学大会(ECCMID)，ECCMID是学术界、临床研究机构和业界公认的欧洲最大的分析和讨论临床微生物学和感染病学研究的大会。ECCMID最初每两年召开一次，1999年成为一年一度的盛会。近年来，ECCMID的规模和地位不断提升，现在每年吸引约10,000名参与者，提交的摘要数量已增加到3,000多个，其中65％被接受为口头或海报展示。

ECCMID 2024
34th European Congress of Clinical Microbiology & Infectious Disease

Date: 27 – 30 April 2024
Venue: Fira Barcelona COPENHAGEN (Barcelona, Spain)

ECCMID, as the world’s premier Clinical Microbiology & Infectious Diseases event, brings together experts from many fields to present their latest findings, guidelines and experiences to an audience of over 13,000 colleagues. This year, the Programme Committee has developed a multi-faceted program incorporating keynote lectures and oral sessions, as well as interactive workshops, meet-the-expert sessions, open forums, and a wide range of symposia. Be sure to get involved in all of the exciting educational, social and professional events ECCMID has to offer you!

摘要征文投稿：

• Regular abstract submission: 16 October 2023, 16:00 CET - 29 November 2023, 16:00 CET
• Notification to the abstract submitters: Late January 2024

• Submission: Late January 2024
• Review: End of January / February
• Notification to the abstract submitters: Early March 2024

点此提交摘要>>>Submit Abstract>>>

Abstract type

Abstracts should fall into one of two selectable categories:

1. Regular abstract
2. Case report/series

If ‘Case report/ series’ is selected, the template sections:

Background/Materials/Results/Conclusions will be automatically replaced by:

Background/Case(s) description/Discussion

Authors

Please ensure that all author names are correct upon submission. It is the responsibility of the presenting author to ensure that this is kept up to date in case of changes.

If the submitter is a co-author of the abstract, we kindly ask them to include their information on the author list, as this does not take place automatically.

Please check the correct spelling and formatting of the author(s) names and affiliation(s).

Please use appropriate capitalisation and punctuation.

ESCMID takes no responsibility for errors in either author or affiliation information.

Text

ALL CAPS for text (other than abbreviations or acronyms) are not allowed. The text of the entire abstract must not exceed 350 words (excluding figure descriptions and references). Use British English spelling.

Title

The abstract title should be concise and submitted in line with scientific rules. This applies to special characters and words that must be CAPITALISED or italicised.

• Please DO NOT capitalise the title except the first word
• Please DO NOT use a dot to finish the title
• Please DO NOT use any brand names in the title

ESCMID reserves the right to proofread and adjust titles according to ECCMID guidelines format without the consent of the author.

Abstract body

Use the provided fields to draft your abstract. Please ensure that different sections of your abstract are entered into the appropriate textbox. For research abstracts, briefly state the background, context of research, and its goals.

The methods section should provide the minimum required information on the research setting, data collection, and analytical methods.

The results presented in the abstract should be original, not published or presented previously.

For Case report/series and CGR cases (usually featuring a single illustrative case or a series of up to 10 cases), emphasise the unique aspects of the case (e.g. with respect to clinical presentation, diagnosis or treatment) and discuss the learning points emerging from the case(s).

Narrative reviews or abstracts without genuine data content cannot be accepted.

Pictures/Graphs/Tables

Please use the figure upload fields at the bottom to select up to three images. Figure sections can be used to upload images, graphs, or tables.

Accepted formats: JPEG or PNG. Size: 1000x1000 pixels max. File size: up to 5 MB. Images larger than the provided dimensions will be automatically resized to an A4 format in your submission confirmation.

Please check the readability of uploaded materials before submitting your abstract.

Spelling guidelines

Use British English spelling throughout. The International System of Units (SI) should be used wherever appropriate. Genus and species names should be written in full as mentioned first and abbreviated subsequently. Italicise when appropriate.

The following scientific rules apply (examples in brackets):

• Systematic names (genus, family, and higher orders): capitalised (e.g., Chlamydia, Enterobacterales Picornaviridae)
• Non-English expressions in English texts are written in italics (e.g., in vitro/in vivo, ad hoc, ex officio)
• Taxonomic names must be italicised (e.g., Staphylococcus aureus, Clostridium difficile)
• Non-systematic names (e.g., plural): lowercase and not italicised (group A streptococci, mycobacteria)
• Generic drug names: lowercase (e.g., penicillin)
• Do not use brand names in titles: product names are allowed in the abstract text, but must be avoided in the title
• Please follow standard English grammar rules, including a space after full stops and commas
• Only common abbreviations may be used without definition

Abstract topics

The full list of abstract topics may be found here.

Please choose the best-fitting abstract category and sub-category to ensure allocation for review by the most suitable reviewing experts and best fit to the session in case of acceptance.

All case and case series abstracts will be automatically assigned to category 12. Case reports and case series (n<10).

Keywords

Authors are asked to choose two keywords from the dropdown and one free keyword to define the best abstract content.

Submit your abstract

You can save your abstract at any time. Please make sure to fill all fields correctly before final submission. Changes in the abstract are not possible after submission. After submission, an email confirmation will be sent to the submitter (please state your correct email address!). All co-authors will be notified by email and receive a copy of the submitted abstract. The submitter is responsible for obtaining permission for submission and presentation of the abstract from all co-authors and any relevant stakeholders. All correspondence regarding acceptance or rejection, including further information on the mode of presentation, etc., will be sent to the presenting author.

If an abstract is not accepted for an oral presentation, it may be accepted as a poster presentation, and the presenting authors will receive notification via email. 

Should you decide to change the type of abstract once you have started the submission, please withdraw your current abstract and re-start the submission process with new content.

ECCMID 2024 注册费：

1 Young Physician / Scientist: as per the ESCMID Young Scientist Membership definition

2 Student: copy of student ID required (English language)

3 Nurse / MLA: proof (employment status) required (English language)

4 As per the ESCMID Low- and Lower-Middle Income Country (LMIC) Membership definition (If this applies to you, please contact escmidmembership[at]escmid.org to obtain this registration)

5 Day Tickets are available from 14 March 2024 (only in person/onsite and only if appropriate) and do not include public transportation passes.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。